Specifically, diminished STAT1 activation can lead to low HLA class I expression, which impairs the effectiveness of cytotoxic T lymphocyte (CTL) responses in mediating tumor elimination and mediates TAP1-dependent escape from CTL [45,46]. The gene discussed is TAP1; the disease is neoplasm.